June 30, 2022

Tact.ai’s New Customer Engagement Capabilities Help Pharma Close the Access Gap and Improve Personalized Connections with HCPs

Sunnyvale, CA
Tact now supports remote engagement with approved content sharing through native MS Teams integration and enhanced field-triggered email in a compliant manner

Tact.ai, the customer engagement company for life sciences, announced today a set of new capabilities that improve customer access for the field. The new capabilities help teams appear in customer inboxes more frequently, and work where the HCPs want to work – like Microsoft Teams for remote engagement – in a compliant way whilst providing them the data & content they need to deliver personalized journeys across all channels.

Now supporting a third of the top 15 global pharma companies, Tact helps shape more personalized and meaningful customer experiences across channels. The platform serves as an engagement layer bringing together CRM, BI, data and insights investments, as well as other customer solutions into a unified system of engagement. Acting as a single pane of glass for all customer communications and collaboration, Tact helps teams achieve greater effectiveness and productivity at scale. Gartner Research noted, “almost everyone had to adopt some form of digital behavior over the past 20 months, and most of those behaviors will stick.”

This includes channels like chat and video meetings, adoption of new tools and devices like Teams and more. In fact, FierceHealthcare.com stated, “…many hospitals and health systems adopted Microsoft Teams to connect clinicians and patients on video.” Preference for such experiences have become the norm, as pharma continues looking for ways to accelerate omnichannel capabilities that allow the field to deliver the content, resources and experiences individual physicians want.

To minimize the loss of personal connections between pharma and HCPs, and bolster trust in relationships, Tact unveils a set of new capabilities to help them succeed with hybrid engagement. 

Tact Content Player for MS Teams allows customer-facing teams to connect where customers prefer by supporting compliant video meetings on Microsoft Teams, sharing compliant content to enable 
better customer access and an improved user experience.

Customer Friendly Email (CFE) offers a reimagined compliant email experience created to help teams send more personalized communications, and appear in their customers’ inboxes more frequently with results as high as 1.5x industry open-rates.

“No one in healthcare or life sciences has been more affected than customers, including physicians and their patients,” said Chuck Ganapathi, founder and CEO of Tact.ai. “There’s a shift happening across the entire industry to use data and content more effectively with HCPs and healthcare organizations. Life sciences can now deliver a total experience with internal and external collaboration central to their mission of delivering innovative new medicines to more patients in need.”

AI-powered customer engagement in life sciences has garnered significant interest from technology and life science leaders. In March, Tact.ai received from Hikma its fourth life sciences industry investment in the past six months -- following its $33 million USD fundraise last year from Novartis (dRxCapital), Lilly and McKesson Ventures at the end of 2021. The next month in April, former Novartis Pharma Global CIO and SVP, Andreas Müller, joined Tact.ai as an Advisor and Chair for its Customer Advisory Board.

share this
facebook icontwitter iconmail iconshare iconlinkedin icon
Subscribe for regular updates!
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.

Featured Posts

No items found.


The Customer Engagement Company for Life Sciences

Tact.ai is on a mission to help life science organizations nurture meaningful customer engagement through our human-friendly software. Our AI-powered engagement platform empowers field teams to work with their customers in new ways to drive better outcomes. Tact.ai is headquartered in Silicon Valley and is backed by some of the world’s leading firms in venture capital, technology, and healthcare and life sciences, including Microsoft’s venture fund M12, Salesforce Ventures, Novartis, Lilly and McKesson Ventures. Visit us at: https://www.tact.ai/